D. Rizos

ORCID: 0000-0001-6813-3940 · 1 paper in corpus · active 1997

Study types

  • article 1
article 1997
·doi:10.3109/09513599709152522

Twenty-one women presenting with different diseases, with absolute or relative contraindications to hormonal contraception or the use of intrauterine devices, received 300-600 micrograms/day buserelin intranasally from the 1st to the 21st d…